Results 171 to 180 of about 14,305,857 (307)
Chiral separation of chloroalkanes with the chromatographic column onboard Martian rovers
Computer image of the Rosalind Franklin Rover of ESA's ExoMars mission. ExoMars is scheduled to land on planet Mars in Oxia Planum in 2029. This area represents an interesting spot to look for biosignatures. Investigations of ExoMars include measurement on molecular chirality. We show that chiral chloroalkanes, that have been identified on Mars, can be
Asma Merzougui +4 more
wiley +1 more source
Heterodimeric amino acid transporters consist of SLC7 and SLC3 family proteins arranged in a conserved structural organization. They regulate nutrient transport across cell membranes, supporting essential cellular functions. These transporters also contribute to xenobiotic/drug uptake and distribution.
Mariafrancesca Scalise +5 more
wiley +1 more source
Comparative Study of Journal Impact Factor and Self-Citation Across Asian International Journals
The aim of this research is to explore journal self-citation, as well as its impact on the outcomes of frequently used major citation analysis indicators.
Wen-Yau Cathy Lin
core
Detronizacija faktora utjecaja?! - pojava novog, besplatnog metričkog pokazatelja, SCImago Journal Ranka [PDF]
Macan, B.
doaj
Are the Editors Responsible for Our Obsession with the Impact Factor?
Juan Carlos Argüelles +1 more
doaj +1 more source
Leucine‐rich glioma inactivated 1 (LGI1) is a ganglioside‐binding protein
Neuronal hyperexcitability associated with a decrease/absence of the extracellular protein LGI1 has been suggested to be primarily due to the downregulation of Kv1 channel expression. The molecular mechanisms underlying this decrease have not yet been elucidated.
Kévin Debreux +7 more
wiley +1 more source
Inflation of the journal impact factor. [PDF]
Ziegler J +4 more
europepmc +1 more source
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos +9 more
wiley +1 more source
Up and Down of Cancer Research and Treatment (CRT)'s Journal Impact Factor at the Moment of CRT's 60th Anniversary. [PDF]
Ahn YC.
europepmc +1 more source

